Immunochina's Unattributed VC Round

Immunochina raised a round of funding on November 24, 2017.

Immunochina (艺妙神州医疗) is a cancer diagnosis and treatment service provider based on immune cell therapy CAR-T, which is independently developed from the aspects of plasmid production, prepa…

Articles about Immunochina's Unattributed VC Round: